Women's Health
News
Trastuzumab Benefit Persists at 4 Years in HER2-Positive Breast Cancer
Major Finding: Disease-free survival at a median follow-up of 48.4 months in 1,703 women initially randomized to receive 1 year of treatment with...
News
FDA Grants Hearing on Withdrawal of Bevacizumab Approval
News
Abortion Rate Fell in 2007
News
ASCO Revises Guideline on Bone Metastases in Breast Cancer
Major Finding: An updated guideline on the use of bone-modifying agents to prevent or treat bone metastases in patients with metastatic breast...
News
Nitroglycerin Ointment Modestly Raises BMD and Strengthens Bone
Major Finding: Compared with placebo, topical nitroglycerin ointment increased bone mineral density in the lumbar spine, total hip, and femoral...
News
Rapid Intrapartum GBS Test Outperforms Antepartum Culture
Major Finding: The rapid intrapartum GBS test, compared with antepartum culture, had a significantly better sensitivity (91% vs. 69%) and negative...
News
Potential Risks to Newborns Being Added to Antipsychotics' Pregnancy Labels
News
House Votes to Strip Planned Parenthood of Funding
News
Contingent Test for Down Syndrome Tops for Cost-Effectiveness
Major Finding: Overall, the contingent screening test showed a cost-effectiveness ratio of $26,833 Canadian dollars per case of DS.
News
FDA Warns About CV Deaths, Risks With Obstetric Terbutaline Use
News
CBT, Graded Exercise Therapy Help Chronic Fatigue Syndrome
Major Finding: For patients with chronic fatigue syndrome, mean physical function scores were significantly higher at 1-year follow-up for both...